|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stone WL, Krishnan K, Campbell SE and
Palau VE: The role of antioxidants and pro-oxidants in colon
cancer. World J Gastrointest Oncol. 6:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sreevalsan S and Safe S: Reactive oxygen
species and colorectal cancer. Curr Colorectal Cancer Rep.
9:350–357. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saud SM, Li W, Morris NL, Matter MS,
Colburn NH, Kim YS and Young MR: Resveratrol prevents tumorigenesis
in mouse model of Kras activated sporadic colorectal cancer by
suppressing oncogenic Kras expression. Carcinogenesis.
35:2778–2786. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bond CE, Liu C, Kawamata F, McKeone DM,
Fernando W, Jamieson S, Pearson SA, Kane A, Woods SL, Lannagan TRM,
et al: Oncogenic BRAF mutation induces DNA methylation changes in a
murine model for human serrated colorectal neoplasia. Epigenetics.
13:40–48. 2018.PubMed/NCBI
|
|
6
|
Myers JN, Schäffer MW, Korolkova OY,
Williams AD, Gangula PR and M'Koma AE: Implications of the colonic
deposition of free hemoglobin-α chain: A previously unknown tissue
by-product in inflammatory bowel disease. Inflamm Bowel Dis.
20:1530–1547. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Federico A, Morgillo F, Tuccillo C,
Ciardiello F and Loguercio C: Chronic inflammation and oxidative
stress in human carcinogenesis. Int J Cancer. 121:2381–2386. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barrett CW, Ning W, Chen X, Smith JJ,
Washington MK, Hill KE, Coburn LA, Peek RM, Chaturvedi R, Wilson
KT, et al: Tumor suppressor function of the plasma glutathione
peroxidase gpx3 in colitis-associated carcinoma. Cancer Res.
73:1245–1255. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maliepaard M, Scheffer GL, Faneyte IF, van
Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper
RJ and Schellens JH: Subcellular localization and distribution of
the breast cancer resistance protein transporter in normal human
tissues. Cancer Res. 61:3458–3464. 2001.PubMed/NCBI
|
|
10
|
Pavek P, Merino G, Wagenaar E, Bolscher E,
Novotna M, Jonker JW and Schinkel AH: Human breast cancer
resistance protein: Interactions with steroid drugs, hormones, the
dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine,
and transport of cimetidine. J Pharmacol Exp Ther. 312:144–152.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen S and Zhang W: ABC transporters and
drug efflux at the blood-brain barrier. Rev Neurosci. 21:29–53.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Westover D and Li F: New trends for
overcoming ABCG2/BCRP-mediated resistance to cancer therapies. J
Exp Clin Cancer Res. 34:1592015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gupta N, Martin PM, Miyauchi S, Ananth S,
Herdman AV, Martindale RG, Podolsky R and Ganapathy V:
Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer.
Biochem Biophys Res Commun. 343:571–577. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu HG, Pan YF, You J, Wang OC, Huang KT
and Zhang XH: Expression of ABCG2 and its significance in
colorectal cancer. Asian Pac J Cancer Prev. 11:845–848.
2010.PubMed/NCBI
|
|
15
|
Shen S, Callaghan D, Juzwik C, Xiong H,
Huang P and Zhang W: ABCG2 reduces ROS-mediated toxicity and
inflammation: A potential role in Alzheimer's disease. J Neurochem.
114:1590–1604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ, Wills QF, Tipping AJ, Datta K,
Mittal R, Goldson AJ, Sexton DW and Holmes CC: Methods for qPCR
gene expression profiling applied to 1440 lymphoblastoid single
cells. Methods. 59:71–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duan G, Tang Q, Yan H, Xie L, Wang Y,
Zheng XE, Zhuge Y, Shen S, Zhang B, Zhang X, et al: A strategy to
delay the development of cisplatin resistance by maintaining a
certain amount of cisplatin-sensitive cells. Sci Rep. 7:4322017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W, Chen H, Yu M and Fang J: Targeted
delivery of doxorubicin using a colorectal cancer-specific ssDNA
aptamer. Anat Rec (Hoboken). 297:2280–2288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karin M: NF-kappaB and cancer: Mechanisms
and targets. Mol Carcinog. 45:355–361. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park MY, Kim MY, Seo YR, Kim JS and Sung
MK: High-fat diet accelerates intestinal tumorigenesis through
disrupting intestinal cell membrane integrity. J Cancer Prev.
21:95–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Perše M: Oxidative stress in the
pathogenesis of colorectal cancer: Cause or consequence? BioMed Res
Int. 2013:7257102013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Obtułowicz T, Winczura A, Speina E,
Swoboda M, Janik J, Janowska B, Cieśla JM, Kowalczyk P, Jawien A
and Gackowski D: Aberrant repair of etheno-DNA adducts in
leukocytes and colon tissue of colon cancer patients. Free Radic
Biol Med. 49:1064–1071. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan Y, Yang Z, Miao X, Li D, Liu Z and
Zou Q: The clinical significance of FRAT1 and ABCG2 expression in
pancreatic ductal adenocarcinoma. Tumour Biol. 36:9961–9968. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Krishnamurthy P, Xie T and Schuetz JD: The
role of transporters in cellular heme and porphyrin homeostasis.
Pharmacol Ther. 114:345–358. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ogino T, Kobuchi H, Munetomo K, Fujita H,
Yamamoto M, Utsumi T, Inoue K, Shuin T, Sasaki J, Inoue M, et al:
Serum-dependent export of protoporphyrin IX by ATP-binding cassette
transporter G2 in T24 cells. Mol Cell Biochem. 358:297–307. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gnana-Prakasam JP, Reddy SK,
Veeranan-Karmegam R, Smith SB, Martin PM and Ganapathy V: Polarized
distribution of heme transporters in retinal pigment epithelium and
their regulation in the iron-overload disease hemochromatosis.
Invest Ophthalmol Vis Sci. 52:9279–9286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brechbuhl HM, Gould N, Kachadourian R,
Riekhof WR, Voelker DR and Day BJ: Glutathione transport is a
unique function of the ATP-binding cassette protein ABCG2. J Biol
Chem. 285:16582–16587. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Krzyżanowski D, Bartosz G and Grzelak A:
Collateral sensitivity: ABCG2-overexpressing cells are more
vulnerable to oxidative stress. Free Radic Biol Med. 76:47–52.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reuter S, Gupta SC, Chaturvedi MM and
Aggarwal BB: Oxidative stress, inflammation, and cancer: How are
they linked? Free Radic Biol Med. 49:1603–1616. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Satapati S, Kucejova B, Duarte JA,
Fletcher JA, Reynolds L, Sunny NE, He T, Nair LA, Livingston KA, Fu
X, et al: Mitochondrial metabolism mediates oxidative stress and
inflammation in fatty liver. J Clin Invest. 125:4447–4462. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Morgan MJ and Liu ZG: Crosstalk of
reactive oxygen species and NF-κB signaling. Cell Res. 21:103–115.
2011. View Article : Google Scholar : PubMed/NCBI
|
